AI-generated summary reviewed by our newsroom. Read our AI Policy. Voters will soon get their first look at who plans to run in North Carolina’s next election cycle. Candidate filing for the 2026 ...
If Auburn can stick to athletic director John Cohen’s desired timeline, it’s only two days away from naming its next head coach. Friday featured a key development to that process. Tulane head coach ...
One of Auburn top head coaching candidates is reportedly the favorite to land a different SEC job. Tulane head coach Jon Sumrall is now the favorite to become Florida’s next head coach, according to a ...
Microsoft warned users on Tuesday that FIDO2 security keys may prompt them to enter a PIN when signing in after installing Windows updates released since the September 2025 preview update. This ...
Hosted on MSN
Key member of Kalen DeBoer's Alabama coaching staff named as a candidate for recently opened head coaching job
A key member of Kalen DeBoer's Alabama Crimson Tide coaching staff could be a candidate for a recently opened head coaching job. On Sunday, California fired head coach Justin Wilcox. The move came ...
Ed Hale, Republican candidate for Maryland governor, addresses the rising costs and delays in rebuilding the Francis Scott Key Bridge and shared his views on the state’s economic issues. Hale spoke on ...
Penn State has embarked on one of college football’s most high-profile coaching searches to replace James Franklin, who was fired Oct. 12. Athletic Director Pat Kraft promised a nationwide search for ...
Bradescu raised twice as much as the incumbent yet lost by nearly 50 percentage points. Jimmy Hallyburton spent less per vote and leveraged incumbent recognition to win. Campaign spending targeted ...
Brent Key and the Georgia Tech Yellow Jackets are 8-1 with a Week 12 matchup against the Boston College Eagles. It has been an impressive season with the Yellow Jackets sitting at No. 16 in the ...
Trial tests drug against relapsing form of the disease Drug candidate as effective as Roche's Ocrevus in a separate study Fenebrutinib could bring in over $1 billion in annual peak sales FRANKFURT, ...
FRANKFURT (Reuters) -Swiss drugmaker Roche said on Monday that a late-stage trial testing its multiple sclerosis drug candidate fenebrutinib against the relapsing form of the disease achieved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback